Allogeneic haemopoietic cell transplant services in Australia and New Zealand in the first year of the COVID‐19 pandemic: a report from Australia and New Zealand transplant and cellular therapies.
In: Internal Medicine Journal, Jg. 53 (2023-03-01), Heft 3, S. 323-329
Online
academicJournal
Zugriff:
Background: The COVID‐19 pandemic has caused major disruption to health systems, with allogeneic haemopoietic cell transplant (alloHCT) services a particularly vulnerable area. Ongoing provision of alloHCT has required dynamic responses at national and local levels. In Australia and New Zealand (ANZ), a high reliance on unrelated donors from overseas registries has posed an additional challenge. Aims: To describe the impact of COVID‐19 on alloHCT services in ANZ in the first year of the pandemic. Methods: Data from the national alloHCT patient and unrelated donor registries were extracted for a 2‐year time frame. Comparisons were made between a pre‐pandemic period of 1 March 2019 to 29 February 2020 and the corresponding dates during the pandemic, 1 March 2020 to 28 February 2021. Results: There was a 13% decrease in the number of allogeneic transplants, a reversal of steady increases in previous years, with the largest decrease in unrelated donor transplants. Local donors supplied a greater proportion of unrelated stem cell products. With a switch to universal cryopreservation, the time from request of a product to infusion increased by a median of 25.5 days for overseas products and 14 days for local products. There was a significant increase in the number of products collected but not used. Conclusions: A strong public health response and coordinated transplant community activities allowed for safe provision of alloHCT in ANZ; however, our data suggest that the timely delivery of allogeneic transplants was affected by the COVID‐19 pandemic. Continued dedicated efforts are required to minimise further impacts. [ABSTRACT FROM AUTHOR]
Copyright of Internal Medicine Journal is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Allogeneic haemopoietic cell transplant services in Australia and New Zealand in the first year of the COVID‐19 pandemic: a report from Australia and New Zealand transplant and cellular therapies.
|
---|---|
Autor/in / Beteiligte Person: | Othman, Jad ; Aarons, Donna ; Bajel, Ashish ; Butler, Jason ; Doocey, Richard ; O'Brien, Tracey ; Purtill, Duncan ; Smith, Lisa ; Wilcox, Leonie ; Hamad, Nada |
Link: | |
Zeitschrift: | Internal Medicine Journal, Jg. 53 (2023-03-01), Heft 3, S. 323-329 |
Veröffentlichung: | 2023 |
Medientyp: | academicJournal |
ISSN: | 1444-0903 (print) |
DOI: | 10.1111/imj.15886 |
Schlagwort: |
|
Sonstiges: |
|